Israel Englander’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,000
Closed -$568K 6446
2023
Q4
$568K Buy
+10,000
New +$524K ﹤0.01% 4564
2022
Q3
Sell
-6,000
Closed -$273K 7317
2022
Q2
$273K Buy
+6,000
New +$268K ﹤0.01% 5443
2022
Q1
Sell
-20,000
Closed -$1M 7226
2021
Q4
$1M Hold
20,000
﹤0.01% 4403
2021
Q3
$1.06M Hold
20,000
﹤0.01% 4610
2021
Q2
$1.22M Hold
20,000
﹤0.01% 4488
2021
Q1
$976K Buy
+20,000
New +$937K ﹤0.01% 4244
2020
Q3
Sell
-20,000
Closed -$528K 4662
2020
Q2
$528K Buy
+20,000
New +$523K ﹤0.01% 3372
2020
Q1
Sell
-30,000
Closed -$1.08M 4211
2019
Q4
$1.08M Buy
+30,000
New +$1.04M ﹤0.01% 2969
2019
Q2
Sell
-20,000
Closed -$620K 4287
2019
Q1
$620K Buy
+20,000
New +$534K ﹤0.01% 3138
2018
Q3
Sell
-10,000
Closed -$335K 4114
2018
Q2
$335K Buy
+10,000
New +$356K ﹤0.01% 3336

Other funds holding LMAT

Israel Englander's LMAT Position: Q2 2026 in Review

Israel Englander reduced its LeMaitre Vascular (LMAT) stake by 83% in Q2 2026, selling an estimated $4.61M and leaving 8,994 shares worth $863K. The position accounts for ﹤0.01% of the portfolio, ranked #4414.

Israel Englander first reported a position in LMAT in Q4 2013 and has held it in 42 quarters since. The position peaked at $24.1M in Q2 2025. 325 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Israel Englander held 8,994 shares of LeMaitre Vascular worth $863K as of Q2 2026.
  • Israel Englander sold 45,012 LeMaitre Vascular shares in Q2 2026, an estimated $4.61M.
  • LeMaitre Vascular made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4414 holding.
  • Israel Englander first reported a position in LeMaitre Vascular in Q4 2013 and has held it in 42 quarters since.
  • Israel Englander's LeMaitre Vascular position peaked at $24.1M in Q2 2025.
  • 325 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.